InvestorsHub Logo
Post# of 252496
Next 10
Followers 1
Posts 132
Boards Moderated 0
Alias Born 07/19/2010

Re: DewDiligence post# 99877

Tuesday, 07/27/2010 4:34:46 PM

Tuesday, July 27, 2010 4:34:46 PM

Post# of 252496
Can you imagine that FDA's demand for a complicated molecule such as Copaxone would be less (without bioequivalence) than for a simple compound such as aspirin?
Thanks for your welcoming.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.